Bharat Biotech International Ltd. engages in research and development, manufacturing, marketing and distribution of vaccines and biotherapeutics. It focuses on the development of novel health care solutions for region-specific neglected diseases. The firm offers Revac-B+, REGEN-D, HNVAC, COMVAC5, BIOPOLIO, INDIRAB, Typbar TCV, BIOHIB, JENVAC, ROTAVAC and vaccine candidates against chikungunya, chandipura, HPV and Ebola. The company was founded by Krishna Murthy Ella and Suchitra K. Ella in 1996 and is headquartered in Hyderabad, India..

VLife provides high performance, accurate and reliable solutions for improving productivity in drug and molecular discovery. VLife's products are benchmarked as 'Best in Class' for a wide spectrum of critical research objectives and functionalities. VLife products ensure that researchers get 'All applications for a specific domain in one product'. If a researcher is focused on: 1.QSAR only, all they have to license in is the QSARProâ„¢ 2.Protein modeling and Docking, BioPredictaâ„¢ is all one needs 3.Cheminformatics, then product of choice is ChemXplorâ„¢ 4.If the scientists' interest is across CADD workspace, they can license VLifeMDSâ„¢; the comprehensive flagship product of VLife

Yung Shin Pharmaceutical Industrial Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include active pharmaceutical ingredients, traditional Chinese medicine, human medicine, animal medicine, food products, and medical equipment. The company was founded by Tien Te Li in 1952 and is headquartered in Taichung, Taiwan.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Gottlieb Binder GmbH & Co. KG is a private company headquartered in Holzgerlingen, Germany. The firm manufactures and supplies mushroom closures, caps, profiles, hook & loop fasteners. It was founded in 1798. Patrick Geffers, Axel Schulte and Konstantinos Poulakis are the current co-CEOs of the company.

Tam is a private company headquartered in Montelimar, France. The firm trades cars and light motor vehicles.

AiViva BioPharma, Inc. is a privately held clinical-stage biotech company that is developing revolutionary technologies to meet unmet medical needs by converting current medicines to generate localized, targeted disease treatment while reducing systemic exposure. Their expertise includes the creation of pharmaceuticals in the specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology utilizing their unique JELTM Technology. They are developing formulations, oncology, dermatology, ophthalmology, clinical, and delivery formulations.

CMC Consulting Boston, Inc engages in the provision of advisory services. It offers strategy and market positioning, market segmentation, and trend analysis services. The firm serves the pharmaceutical, life sciences, healthcare, and information technology markets. The company was founded in 1999 and is headquartered in Boston, MA.

Alloksys Life Sciences BV provides therapies services. It offers Phase 3 clinical trials leading to registration of RESCAP (RESCuing Alkaline Phosphatase) for the prevention and treatment of ischemic injury and inflammation mediated complications in cardiothoracic surgery (APPIRED III). The company was founded by Ruud Brands in 2005 and is headquartered in Wageningen, the Netherlands.

TNO is an independent research organization with approximately 3,000 employees. They believe in joint creation of value in social and economic terms. They focus on transitions or changes in five social themes: Industry, Healthy Living, Defense & Safety, Environment and Energy. Targeted innovation, which is what TNO stands. They develop knowledge not about knowledge, but about practical application.

Fresenius Kabi Deutschland GmbH, part of Fresenius SE & Co. KGaA, is a company headquartered in Bad Homburg vor der Hohe, Germany, that manufactures drugs in pharmaceutical preparations for human and veterinary use. The firm was founded in 1999. Steffen Roser, Christoph Funke and Tanja Greve are the current co-CEOs of the company.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Coll-Med Ltd. develops burn treatment devices based on collagen extracted from Rhopilema Nomadica jellyfish. It offers film which will be sterilized and contains antiseptic substances to prevent bacterial attack and will be porous to aid in exudates removal. The company was founded in 2008 and is headquartered in Migdal HaEmek, IL.

Suzhou Adwansi New Materials Co., Ltd., established on 2018-06-28, Business scope includes new material technology,Technology development in the field of environmental technology,technology transfer,technical consulting,Technical Services;Sales:Chemical Products(Free of Hazardous Chemicals),office equipment,glassware,Experimental consumables,Instrumentation,metallic material,building materials,ceramics;Intellectual Property Agency Services,Intellectual Property Consulting Services;Development of computer software and hardware,Install,maintain,technical consulting,Technical Services;research and development,design,Sales:Green facilities;And provide technical services for sales of related products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The First Hospital of Jilin University, a subsidiary of Jilin University, is a Chinese company located in Changchun. The firm owns and operates hospital.

Shilpa Medicare Ltd. engages in the manufacturing of pharmaceutical products and wind power generation. The company was founded on November 20, 1987 and is headquartered in Raichur, India.

Bruin Biometrics, LLC (“BBI”) is a multi-member partnership formed in 2009 and has exclusively licensed wireless health technologies from the UCLA Wireless Health Institute. BBI’s mission is to develop a robust portfolio of patent-protected, FDA-approved wireless health devices targeting significant medical conditions and unmet medical needs. The lead product under development is the Sub-Epidermal Moisture (“SEM”) Scanner Device used to detect pressure ulcers.